The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease

Endocr Rev. 1998 Oct;19(5):583-92. doi: 10.1210/edrv.19.5.0343.
No abstract available

Publication types

  • Review

MeSH terms

  • Acarbose
  • Adult
  • Aged
  • Aged, 80 and over
  • Arteriosclerosis / etiology*
  • Arteriosclerosis / prevention & control
  • Biguanides / pharmacology
  • Biguanides / therapeutic use
  • Blood Glucose / metabolism
  • Blood Glucose / physiology
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / metabolism
  • Fasting / metabolism
  • Fasting / physiology
  • Female
  • Humans
  • Hyperglycemia / complications*
  • Hyperglycemia / metabolism
  • Hyperglycemia / physiopathology
  • Hyperinsulinism / complications
  • Hyperinsulinism / metabolism
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Insulin / metabolism
  • Insulin / pharmacology
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Postprandial Period / physiology
  • Sulfonylurea Compounds / pharmacology
  • Sulfonylurea Compounds / therapeutic use
  • Trisaccharides / pharmacology
  • Trisaccharides / therapeutic use

Substances

  • Biguanides
  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Sulfonylurea Compounds
  • Trisaccharides
  • Acarbose